Drug information for TRANDOLAPRIL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
COREPHARMA
77256
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
COREPHARMA
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
COREPHARMA
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
CIPLA
77307
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
CIPLA
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
CIPLA
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
TEVA PHARMS
77489
2006-12-28 Letter
2006-12-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
TEVA PHARMS
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
TEVA PHARMS
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
LUPIN
77522
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
LUPIN
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
LUPIN
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
WATSON LABS
77805
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
WATSON LABS
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
WATSON LABS
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
INVAGEN PHARMS
78320
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
INVAGEN PHARMS
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
INVAGEN PHARMS
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
MYLAN
78346
2008-05-02 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
MYLAN
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
MYLAN
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
AUROBINDO PHARMA
78438
2007-06-18 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
AUROBINDO PHARMA
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
AUROBINDO PHARMA
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
DR REDDYS LABS LTD
78493
2008-09-19 Other Important Information from FDA
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
DR REDDYS LABS LTD
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
DR REDDYS LABS LTD
"
TABLET; ORAL
1MG
Prescription
AB
TRANDOLAPRIL
trandolapril
EPIC PHARMA
78508
TABLET; ORAL
2MG
Prescription
AB
TRANDOLAPRIL
trandolapril
EPIC PHARMA
"
TABLET; ORAL
4MG
Prescription
AB
TRANDOLAPRIL
trandolapril
EPIC PHARMA
"
Drug Adverse Effects information for TRANDOLAPRIL
Role code
Indications
Reaction
# Reports
C
ABDOMINAL PAIN UPPER
HAEMOGLOBIN DECREASED
1
C
ABDOMINAL PAIN UPPER
IMPETIGO
1
C
ABDOMINAL PAIN UPPER
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
ANTICOAGULANT THERAPY
BLOOD CREATININE INCREASED
1
C
ANTICOAGULANT THERAPY
RECTAL HAEMORRHAGE
1
C
ANXIETY
CANDIDIASIS
1
C
ANXIETY
COGNITIVE DISORDER
1
C
ANXIETY
DIARRHOEA
1
C
ANXIETY
ESCHERICHIA INFECTION
1
C
ANXIETY
GASTROINTESTINAL NECROSIS
1
C
ANXIETY
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
ANXIETY
HEPATIC CIRRHOSIS
1
C
ANXIETY
HEPATORENAL SYNDROME
1
C
ANXIETY
HYPERKALAEMIA
1
C
ANXIETY
INTUSSUSCEPTION
1
C
ANXIETY
LUNG DISORDER
1
C
ANXIETY
PANCYTOPENIA
1
C
ATRIAL FIBRILLATION
ANAEMIA
2
C
ATRIAL FIBRILLATION
AORTIC ARTERIOSCLEROSIS
1
C
ATRIAL FIBRILLATION
AORTIC STENOSIS
1
C
ATRIAL FIBRILLATION
BLOOD CREATININE INCREASED
1
C
ATRIAL FIBRILLATION
CAROTID ARTERIOSCLEROSIS
1
C
ATRIAL FIBRILLATION
DUODENAL ULCER
2
C
ATRIAL FIBRILLATION
DUODENITIS
1
C
ATRIAL FIBRILLATION
GASTROINTESTINAL HAEMORRHAGE
1
C
ATRIAL FIBRILLATION
HELICOBACTER GASTRITIS
1
C
ATRIAL FIBRILLATION
HYPOTENSION
1
C
ATRIAL FIBRILLATION
INTERNATIONAL NORMALISED RATIO INCREASED
2
C
ATRIAL FIBRILLATION
IRON DEFICIENCY
1
C
ATRIAL FIBRILLATION
MALAISE
2
C
ATRIAL FIBRILLATION
MITRAL VALVE INCOMPETENCE
1
C
ATRIAL FIBRILLATION
OVERDOSE
1
C
ATRIAL FIBRILLATION
PHLEBITIS SUPERFICIAL
1
C
ATRIAL FIBRILLATION
RECTAL HAEMORRHAGE
1
C
ATRIAL FIBRILLATION
VERTEBRAL ARTERY STENOSIS
1
C
ATRIOVENTRICULAR BLOCK COMPLETE
DERMATITIS EXFOLIATIVE
5
C
BLOOD GLUCOSE
INTERSTITIAL LUNG DISEASE
2
C
CARDIAC DISORDER
BLOOD CREATININE INCREASED
1
C
CARDIAC DISORDER
HAEMOGLOBIN DECREASED
2
C
CARDIAC DISORDER
IMPETIGO
2
C
CARDIAC DISORDER
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
2
C
CARDIAC DISORDER
RECTAL HAEMORRHAGE
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
BLOOD CREATININE INCREASED
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
DIARRHOEA
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
LICHEN PLANUS
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
MUSCLE SPASMS
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
RECTAL HAEMORRHAGE
1
C
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
STOMATITIS
1
C
CONSTIPATION
DERMATITIS EXFOLIATIVE
1
C
DEMENTIA ALZHEIMER'S TYPE
ANAEMIA
2
C
DEMENTIA ALZHEIMER'S TYPE
AORTIC ARTERIOSCLEROSIS
1
C
DEMENTIA ALZHEIMER'S TYPE
AORTIC STENOSIS
1
C
DEMENTIA ALZHEIMER'S TYPE
CAROTID ARTERIOSCLEROSIS
1
C
DEMENTIA ALZHEIMER'S TYPE
DUODENAL ULCER
2
C
DEMENTIA ALZHEIMER'S TYPE
DUODENITIS
1
C
DEMENTIA ALZHEIMER'S TYPE
GASTROINTESTINAL HAEMORRHAGE
1
C
DEMENTIA ALZHEIMER'S TYPE
HELICOBACTER GASTRITIS
1
C
DEMENTIA ALZHEIMER'S TYPE
HYPOTENSION
1
C
DEMENTIA ALZHEIMER'S TYPE
INTERNATIONAL NORMALISED RATIO INCREASED
2
C
DEMENTIA ALZHEIMER'S TYPE
IRON DEFICIENCY
1
C
DEMENTIA ALZHEIMER'S TYPE
MALAISE
2
C
DEMENTIA ALZHEIMER'S TYPE
MITRAL VALVE INCOMPETENCE
1
C
DEMENTIA ALZHEIMER'S TYPE
OVERDOSE
1
C
DEMENTIA ALZHEIMER'S TYPE
PHLEBITIS SUPERFICIAL
1
C
DEMENTIA ALZHEIMER'S TYPE
VERTEBRAL ARTERY STENOSIS
1
C
DEPRESSION
HAEMOGLOBIN DECREASED
1
C
DEPRESSION
IMPETIGO
1
C
DEPRESSION
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
DIABETES MELLITUS
HYPOGLYCAEMIA
1
C
DIURETIC THERAPY
BLOOD CREATININE INCREASED
2
C
DIURETIC THERAPY
RECTAL HAEMORRHAGE
2
C
DIZZINESS
DERMATITIS EXFOLIATIVE
1
C
DYSPEPSIA
ABDOMINAL DISTENSION
1
C
DYSPEPSIA
ALANINE AMINOTRANSFERASE INCREASED
1
C
DYSPEPSIA
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
DYSPEPSIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
DYSPEPSIA
BLOOD CREATININE INCREASED
1
C
DYSPEPSIA
DRUG INTERACTION
1
C
DYSPEPSIA
MYOPATHY
1
C
GASTRITIS
DERMATITIS EXFOLIATIVE
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
ANGINA UNSTABLE
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
BLOOD PRESSURE INADEQUATELY CONTROLLED
1
C
GASTROOESOPHAGEAL REFLUX DISEASE
HYPERTENSION
1
C
HEPATITIS C
HAEMOGLOBIN DECREASED
3
C
HEPATITIS C
IMPETIGO
3
C
HEPATITIS C
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
3
C
HYPERCHOLESTEROLAEMIA
BLOOD CREATININE INCREASED
1
C
HYPERCHOLESTEROLAEMIA
RECTAL HAEMORRHAGE
1
C
HYPERLIPIDAEMIA
ABDOMINAL DISTENSION
2
C
HYPERLIPIDAEMIA
ALANINE AMINOTRANSFERASE INCREASED
2
C
HYPERLIPIDAEMIA
ASPARTATE AMINOTRANSFERASE INCREASED
2
C
HYPERLIPIDAEMIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
2
C
HYPERLIPIDAEMIA
BLOOD CREATININE INCREASED
2
C
HYPERLIPIDAEMIA
DERMATITIS EXFOLIATIVE
1
C
HYPERLIPIDAEMIA
DRUG INTERACTION
2
C
HYPERLIPIDAEMIA
MYOPATHY
2
C
HYPERTENSION
ABDOMINAL DISTENSION
3
C
HYPERTENSION
ALANINE AMINOTRANSFERASE INCREASED
3
C
HYPERTENSION
ASPARTATE AMINOTRANSFERASE INCREASED
3
C
HYPERTENSION
BLOOD CREATINE PHOSPHOKINASE INCREASED
3
C
HYPERTENSION
BLOOD CREATININE INCREASED
3
C
HYPERTENSION
COGNITIVE DISORDER
2
C
HYPERTENSION
DRUG INTERACTION
3
C
HYPERTENSION
HAEMOGLOBIN DECREASED
2
C
HYPERTENSION
HYPOGLYCAEMIA
1
C
HYPERTENSION
IMPETIGO
2
C
HYPERTENSION
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
2
C
HYPERTENSION
MYOPATHY
3
C
HYPERTRIGLYCERIDAEMIA
HAEMOGLOBIN DECREASED
1
C
HYPERTRIGLYCERIDAEMIA
IMPETIGO
1
C
HYPERTRIGLYCERIDAEMIA
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
HYPERURICAEMIA
ABDOMINAL DISTENSION
1
C
HYPERURICAEMIA
ALANINE AMINOTRANSFERASE INCREASED
1
C
HYPERURICAEMIA
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
HYPERURICAEMIA
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
HYPERURICAEMIA
BLOOD CREATININE INCREASED
1
C
HYPERURICAEMIA
DRUG INTERACTION
1
C
HYPERURICAEMIA
HAEMOGLOBIN DECREASED
1
C
HYPERURICAEMIA
IMPETIGO
1
C
HYPERURICAEMIA
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
HYPERURICAEMIA
MYOPATHY
1
C
HYPOGONADISM
ABDOMINAL DISTENSION
1
C
HYPOGONADISM
ALANINE AMINOTRANSFERASE INCREASED
1
C
HYPOGONADISM
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
HYPOGONADISM
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
HYPOGONADISM
BLOOD CREATININE INCREASED
1
C
HYPOGONADISM
DRUG INTERACTION
1
C
HYPOGONADISM
MYOPATHY
1
C
HYPOTHYROIDISM
ABDOMINAL DISTENSION
1
C
HYPOTHYROIDISM
ALANINE AMINOTRANSFERASE INCREASED
1
C
HYPOTHYROIDISM
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
HYPOTHYROIDISM
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
HYPOTHYROIDISM
BLOOD CREATININE INCREASED
1
C
HYPOTHYROIDISM
DRUG INTERACTION
1
C
HYPOTHYROIDISM
MYOPATHY
1
C
IMMUNOSUPPRESSION
ABDOMINAL DISTENSION
3
C
IMMUNOSUPPRESSION
ALANINE AMINOTRANSFERASE INCREASED
3
C
IMMUNOSUPPRESSION
ASPARTATE AMINOTRANSFERASE INCREASED
3
C
IMMUNOSUPPRESSION
BLOOD CREATINE PHOSPHOKINASE INCREASED
3
C
IMMUNOSUPPRESSION
BLOOD CREATININE INCREASED
3
C
IMMUNOSUPPRESSION
DRUG INTERACTION
3
C
IMMUNOSUPPRESSION
MYOPATHY
3
C
INSOMNIA
COGNITIVE DISORDER
1
C
INTERSTITIAL LUNG DISEASE
DERMATITIS EXFOLIATIVE
2
C
LUNG NEOPLASM MALIGNANT
CANDIDIASIS
2
C
LUNG NEOPLASM MALIGNANT
DIARRHOEA
2
C
LUNG NEOPLASM MALIGNANT
ESCHERICHIA INFECTION
2
C
LUNG NEOPLASM MALIGNANT
GASTROINTESTINAL NECROSIS
2
C
LUNG NEOPLASM MALIGNANT
GENERAL PHYSICAL HEALTH DETERIORATION
2
C
LUNG NEOPLASM MALIGNANT
HEPATIC CIRRHOSIS
2
C
LUNG NEOPLASM MALIGNANT
HEPATORENAL SYNDROME
2
C
LUNG NEOPLASM MALIGNANT
HYPERKALAEMIA
2
C
LUNG NEOPLASM MALIGNANT
INTUSSUSCEPTION
2
C
LUNG NEOPLASM MALIGNANT
LUNG DISORDER
2
C
LUNG NEOPLASM MALIGNANT
PANCYTOPENIA
2
C
METABOLIC DISORDER
ANGINA UNSTABLE
2
C
METABOLIC DISORDER
BLOOD PRESSURE INADEQUATELY CONTROLLED
1
C
METABOLIC DISORDER
HYPERTENSION
2
C
METASTATIC MALIGNANT MELANOMA
MENTAL STATUS CHANGES
2
C
MULTIPLE MYELOMA
COGNITIVE DISORDER
2
C
MYOCARDIAL ISCHAEMIA
CANDIDIASIS
5
C
MYOCARDIAL ISCHAEMIA
DIARRHOEA
5
C
MYOCARDIAL ISCHAEMIA
ESCHERICHIA INFECTION
5
C
MYOCARDIAL ISCHAEMIA
GASTROINTESTINAL NECROSIS
5
C
MYOCARDIAL ISCHAEMIA
GENERAL PHYSICAL HEALTH DETERIORATION
5
C
MYOCARDIAL ISCHAEMIA
HEPATIC CIRRHOSIS
5
C
MYOCARDIAL ISCHAEMIA
HEPATORENAL SYNDROME
5
C
MYOCARDIAL ISCHAEMIA
HYPERKALAEMIA
5
C
MYOCARDIAL ISCHAEMIA
INTUSSUSCEPTION
5
C
MYOCARDIAL ISCHAEMIA
LUNG DISORDER
5
C
MYOCARDIAL ISCHAEMIA
PANCYTOPENIA
5
C
OSTEOPOROSIS
ABDOMINAL DISTENSION
1
C
OSTEOPOROSIS
ALANINE AMINOTRANSFERASE INCREASED
1
C
OSTEOPOROSIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
OSTEOPOROSIS
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
OSTEOPOROSIS
BLOOD CREATININE INCREASED
1
C
OSTEOPOROSIS
DERMATITIS EXFOLIATIVE
1
C
OSTEOPOROSIS
DRUG INTERACTION
1
C
OSTEOPOROSIS
MYOPATHY
1
C
PAIN
COMA
1
C
PAIN
FALL
1
C
PAIN
HEAD INJURY
1
C
PAIN
MIOSIS
1
C
PARKINSON'S DISEASE
DUODENAL ULCER
2
C
PARKINSON'S DISEASE
MELAENA
2
C
PREMEDICATION
CANDIDIASIS
1
C
PREMEDICATION
DIARRHOEA
1
C
PREMEDICATION
ESCHERICHIA INFECTION
1
C
PREMEDICATION
GASTROINTESTINAL NECROSIS
1
C
PREMEDICATION
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
PREMEDICATION
HEPATIC CIRRHOSIS
1
C
PREMEDICATION
HEPATORENAL SYNDROME
1
C
PREMEDICATION
HYPERKALAEMIA
1
C
PREMEDICATION
INTUSSUSCEPTION
1
C
PREMEDICATION
LUNG DISORDER
1
C
PREMEDICATION
PANCYTOPENIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ABDOMINAL DISTENSION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ALANINE AMINOTRANSFERASE INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
ANGINA UNSTABLE
14
C
PRODUCT USED FOR UNKNOWN INDICATION
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD CREATININE INCREASED
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD PRESSURE INADEQUATELY CONTROLLED
14
C
PRODUCT USED FOR UNKNOWN INDICATION
BRONCHOPNEUMONIA
14
C
PRODUCT USED FOR UNKNOWN INDICATION
CARDIAC FAILURE
14
C
PRODUCT USED FOR UNKNOWN INDICATION
CATHETER SITE INFECTION
14
C
PRODUCT USED FOR UNKNOWN INDICATION
CIRCULATORY COLLAPSE
21
C
PRODUCT USED FOR UNKNOWN INDICATION
COUGH
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DEHYDRATION
21
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPERTENSION
14
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPOPHAGIA
14
C
PRODUCT USED FOR UNKNOWN INDICATION
HYPOTENSION
14
C
PRODUCT USED FOR UNKNOWN INDICATION
MENTAL STATUS CHANGES
3
C
PRODUCT USED FOR UNKNOWN INDICATION
MYOPATHY
1
C
PRODUCT USED FOR UNKNOWN INDICATION
PRODUCT QUALITY ISSUE
1
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL IMPAIRMENT
21
C
PRODUCT USED FOR UNKNOWN INDICATION
RESPIRATION ABNORMAL
1
C
PRODUCT USED FOR UNKNOWN INDICATION
SYNCOPE
14
C
PRODUCT USED FOR UNKNOWN INDICATION
WEIGHT INCREASED
14
C
PROPHYLAXIS
ALOPECIA
15
C
PROPHYLAXIS
ANAEMIA
15
C
PROPHYLAXIS
BRADYCARDIA
15
C
PROPHYLAXIS
DECREASED APPETITE
15
C
PROPHYLAXIS
DIARRHOEA
15
C
PROPHYLAXIS
HAEMOGLOBIN DECREASED
15
C
PROPHYLAXIS
HYPERAMYLASAEMIA
15
C
PROPHYLAXIS
HYPERLIPASAEMIA
15
C
PROPHYLAXIS
HYPERTENSION
15
C
PROPHYLAXIS
HYPOTHYROIDISM
15
C
PROPHYLAXIS
MALAISE
15
C
PROPHYLAXIS
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
15
C
PROPHYLAXIS
PLATELET COUNT DECREASED
15
C
PROPHYLAXIS OF NAUSEA AND VOMITING
CANDIDIASIS
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
DIARRHOEA
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
ESCHERICHIA INFECTION
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
GASTROINTESTINAL NECROSIS
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
HEPATIC CIRRHOSIS
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
HEPATORENAL SYNDROME
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
HYPERKALAEMIA
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
INTUSSUSCEPTION
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
LUNG DISORDER
1
C
PROPHYLAXIS OF NAUSEA AND VOMITING
PANCYTOPENIA
1
C
PROSTATE CANCER
DUODENAL ULCER
2
C
PROSTATE CANCER
MELAENA
2
C
PROSTATE CANCER METASTATIC
DIARRHOEA
1
C
PROSTATE CANCER METASTATIC
PNEUMATOSIS INTESTINALIS
1
C
PROSTATE CANCER METASTATIC
VOMITING
1
C
RENAL CELL CARCINOMA
ALOPECIA
1
C
RENAL CELL CARCINOMA
ANAEMIA
1
C
RENAL CELL CARCINOMA
BRADYCARDIA
1
C
RENAL CELL CARCINOMA
DECREASED APPETITE
1
C
RENAL CELL CARCINOMA
DIARRHOEA
1
C
RENAL CELL CARCINOMA
HAEMOGLOBIN DECREASED
1
C
RENAL CELL CARCINOMA
HYPERAMYLASAEMIA
1
C
RENAL CELL CARCINOMA
HYPERLIPASAEMIA
1
C
RENAL CELL CARCINOMA
HYPERTENSION
1
C
RENAL CELL CARCINOMA
HYPOTHYROIDISM
1
C
RENAL CELL CARCINOMA
MALAISE
1
C
RENAL CELL CARCINOMA
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME
1
C
RENAL CELL CARCINOMA
PLATELET COUNT DECREASED
1
C
RENAL FAILURE
BRONCHOPNEUMONIA
2
C
RENAL FAILURE
CARDIAC FAILURE
2
C
RENAL FAILURE
CATHETER SITE INFECTION
2
C
RENAL FAILURE
CIRCULATORY COLLAPSE
3
C
RENAL FAILURE
DEHYDRATION
3
C
RENAL FAILURE
HYPOPHAGIA
2
C
RENAL FAILURE
HYPOTENSION
2
C
RENAL FAILURE
RENAL IMPAIRMENT
3
C
RENAL FAILURE
SYNCOPE
2
C
RENAL FAILURE
WEIGHT INCREASED
2
C
RHEUMATOID ARTHRITIS
BLOOD CREATININE INCREASED
2
C
RHEUMATOID ARTHRITIS
LYMPHOMA
1
C
RHEUMATOID ARTHRITIS
RENAL FAILURE
2
C
SLEEP DISORDER
BLOOD CREATININE INCREASED
1
C
SLEEP DISORDER
RECTAL HAEMORRHAGE
1
C
SUPPLEMENTATION THERAPY
CANDIDIASIS
1
C
SUPPLEMENTATION THERAPY
DIARRHOEA
1
C
SUPPLEMENTATION THERAPY
ESCHERICHIA INFECTION
1
C
SUPPLEMENTATION THERAPY
GASTROINTESTINAL NECROSIS
1
C
SUPPLEMENTATION THERAPY
GENERAL PHYSICAL HEALTH DETERIORATION
1
C
SUPPLEMENTATION THERAPY
HEPATIC CIRRHOSIS
1
C
SUPPLEMENTATION THERAPY
HEPATORENAL SYNDROME
1
C
SUPPLEMENTATION THERAPY
HYPERKALAEMIA
1
C
SUPPLEMENTATION THERAPY
INTUSSUSCEPTION
1
C
SUPPLEMENTATION THERAPY
LUNG DISORDER
1
C
SUPPLEMENTATION THERAPY
PANCYTOPENIA
1
C
TACHYARRHYTHMIA
DERMATITIS EXFOLIATIVE
2
C
THROMBOSIS PROPHYLAXIS
ABDOMINAL DISTENSION
1
C
THROMBOSIS PROPHYLAXIS
ALANINE AMINOTRANSFERASE INCREASED
1
C
THROMBOSIS PROPHYLAXIS
ASPARTATE AMINOTRANSFERASE INCREASED
1
C
THROMBOSIS PROPHYLAXIS
BLOOD CREATINE PHOSPHOKINASE INCREASED
1
C
THROMBOSIS PROPHYLAXIS
BLOOD CREATININE INCREASED
2
C
THROMBOSIS PROPHYLAXIS
DRUG INTERACTION
1
C
THROMBOSIS PROPHYLAXIS
MYOPATHY
1
C
THROMBOSIS PROPHYLAXIS
RECTAL HAEMORRHAGE
1
C
TYPE 2 DIABETES MELLITUS
INTERSTITIAL LUNG DISEASE
2
C
URTICARIA
HAEMOGLOBIN DECREASED
1
C
URTICARIA
IMPETIGO
1
C
URTICARIA
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
VITAMIN SUPPLEMENTATION
CANDIDIASIS
2
C
VITAMIN SUPPLEMENTATION
DIARRHOEA
2
C
VITAMIN SUPPLEMENTATION
ESCHERICHIA INFECTION
2
C
VITAMIN SUPPLEMENTATION
GASTROINTESTINAL NECROSIS
2
C
VITAMIN SUPPLEMENTATION
GENERAL PHYSICAL HEALTH DETERIORATION
2
C
VITAMIN SUPPLEMENTATION
HEPATIC CIRRHOSIS
2
C
VITAMIN SUPPLEMENTATION
HEPATORENAL SYNDROME
2
C
VITAMIN SUPPLEMENTATION
HYPERKALAEMIA
2
C
VITAMIN SUPPLEMENTATION
INTUSSUSCEPTION
2
C
VITAMIN SUPPLEMENTATION
LUNG DISORDER
2
C
VITAMIN SUPPLEMENTATION
PANCYTOPENIA
2
Ads by Google